The Drug Regulatory Authority of Pakistan (DRAP) has given the approval for urgent-use of the British COVID-19 vaccine, sources
After the approval of the British vaccine from the related authority, AZD1222 may be imported in Pakistan. A Karachi-based pharmaceutical firm will import the British vaccine, whereas, the value of vaccine for the non-public sector can be fastened by the federal government. Earlier on Thursday, it emerged that AstraZeneca had additionally sought approval for its vaccine from Pakistan after China’s Sinopharm.
AstraZeneca had utilized for registration to the Drug Regulatory Authority of Pakistan (DRAP) by a Pakistani pharmaceutical firm in addition to submitting information of the medical trials of the vaccine. It could be famous that Pakistan had introduced to purchase 1.2 million doses of the corona vaccine from Sinopharm, a state-run Chinese language agency, which is growing two COVID-19 vaccines.